Clinical trials
Observational Femur Head Necrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Completed | 6 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medacta International SA | 4 |
| Aesculap AG | 3 |
| Corin | 2 |
| Stryker Trauma and Extremities | 2 |
| Zimmer Biomet | 2 |
| China Medical University Hospital | 1 |
| Dedienne Sante S.A.S. | 1 |
| Dr. Lutfi Kirdar Kartal Training and Research Hospital | 1 |
| National Health Research Institutes, Taiwan | 1 |
| Osaka City University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Femur Head Necrosis | 28 |
| Osteoarthritis, Hip | 9 |
| Osteoarthritis | 6 |
| Femoral Neck Fractures | 4 |
| Hip Dislocation, Congenital | 3 |
| Hip Fractures | 3 |
| Osteonecrosis | 3 |
| Arthritis, Rheumatoid | 2 |
| Developmental Dysplasia of the Hip | 2 |
| Joint Diseases | 2 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.